2nd SOHO Italian Conference

http://www.sohoitaly.it/

 

2nd SOHO Italian Conference
M

CAR-T in R/R MM: Does Idecabtagene Vicleucel Improve ORR? Are LCAR-B38M Cells Safe? Is BCMA-Specific Treatment More Efficient?

By 2nd SOHO Italian Conference FEATURING Massimo Martino
By 2nd SOHO Italian Conference FEATURING Massimo Martino
8 views
January 27, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Myeloma
07:46
2nd SOHO Italian Conference

MM in USA: What Is the Role of Transplant and MRD? How Do Triplets C…

Feat. K. Anderson
06:31
2nd SOHO Italian Conference

Treatment Options for the R/R MM Patients: A Review of the Current D…

Feat. K. Anderson
11:27
2nd SOHO Italian Conference

New Agents for MM: Melflufen, Selinexor, IMiDs, Anti-CD38, ADCs, and…

Feat. F. Raimondo
17:25
2nd SOHO Italian Conference

CAR-T in R/R MM: Does Idecabtagene Vicleucel Improve ORR? Are LCAR-B…

Feat. M. Martino
10:18
2nd SOHO Italian Conference

Autologous Transplant in MM: Reviewing the Current Data on Induction…

Feat. M. Teresa Petrucci
13:38
2nd SOHO Italian Conference

Imaging in MM: What Is the Role of Imaging in Plasma Cell Dyscrasias…

Feat. E. Zamagni
15:09
2nd SOHO Italian Conference

How I Treat Unfit/Frail MM Patients: Is Frailty Measurable and Do No…

Feat. D. Derudas
12:53
2nd SOHO Italian Conference

Genetic Profiling in MM: Can Genomics Help With High-Risk Disease? H…

Feat. N. Bolli
14:14
2nd SOHO Italian Conference

2020 SOHO Update on Smoldering Myeloma: Can Rd/R Prevent Myeloma to …

Feat. M. Mateos
13:36
2nd SOHO Italian Conference

2020 SOHO Update on MM: What Are the Most Promising Novel Agents and…

Feat. K. Anderson
14:16
2nd SOHO Italian Conference

[PRIVATE] State of the Art of MM in USA: What Is the Role of Transpl…

Feat. K. Anderson